HomeCompareCBWBF vs MRK

CBWBF vs MRK: Dividend Comparison 2026

CBWBF yields 2.83% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $17.8K in total portfolio value
10 years
CBWBF
CBWBF
● Live price
2.83%
Share price
$39.71
Annual div
$1.13
5Y div CAGR
25.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.9K
Annual income
$4,756.57
Full CBWBF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — CBWBF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCBWBFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CBWBF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CBWBF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CBWBF
Annual income on $10K today (after 15% tax)
$240.81/yr
After 10yr DRIP, annual income (after tax)
$4,043.08/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MRK beats the other by $4,553.63/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CBWBF + MRK for your $10,000?

CBWBF: 50%MRK: 50%
100% MRK50/50100% CBWBF
Portfolio after 10yr
$48.8K
Annual income
$7,435.17/yr
Blended yield
15.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CBWBF
Analyst Ratings
2
Buy
1
Hold
Consensus: Buy
Altman Z
0.3
Piotroski
5/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CBWBF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCBWBFMRK
Forward yield2.83%2.81%
Annual dividend / share$1.13$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR25.1%32.7%
Portfolio after 10y$39.9K$57.7K
Annual income after 10y$4,756.57$10,113.78
Total dividends collected$17.0K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: CBWBF vs MRK ($10,000, DRIP)

YearCBWBF PortfolioCBWBF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,054$354.42$11,213$373.04$159.00MRK
2$12,286$458.06$12,667$512.06$381.00MRK
3$13,742$595.23$14,439$708.14$697.00MRK
4$15,482$778.34$16,640$988.16$1.2KMRK
5$17,591$1,025.25$19,432$1,394.07$1.8KMRK
6$20,184$1,361.97$23,057$1,992.90$2.9KMRK
7$23,424$1,827.11$27,889$2,894.79$4.5KMRK
8$27,543$2,479.08$34,518$4,286.29$7.0KMRK
9$32,879$3,408.09$43,912$6,494.35$11.0KMRK
10$39,937$4,756.57$57,714$10,113.78$17.8KMRK

CBWBF vs MRK: Complete Analysis 2026

CBWBFStock

Canadian Western Bank provides personal and business banking products and services primarily in Western Canada. The company offers current, savings, notice, cash management, US dollar, and chequing accounts, as well as organization, business trust, and trust fund investment accounts. It also offers commercial lending and real estate, and equipment financing and leasing products; agriculture lending products; mortgages; lines of credits; registered retirement savings loans; consolidation, and vehicle loans; and credit cards. In addition, the company offers cash management services; life and disability insurance products; and ATM, mobile, and online banking services, as well cheque order services. Further, it provides investment products comprising guaranteed investment certificates, US dollars investments plans, registered retirement income funds, tax-free savings accounts, registered education savings plans, and mutual funds, as well as personal and business planning services. Canadian Western Bank was founded in 1984 and is headquartered in Edmonton, Canada.

Full CBWBF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CBWBF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CBWBF vs SCHDCBWBF vs JEPICBWBF vs OCBWBF vs KOCBWBF vs MAINCBWBF vs JNJCBWBF vs ABBVCBWBF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.